Methods for the treatment of gout
AssigneeXoma (US) LLC
InventorAlan M. Solinger
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for the treatment and/or prevention of gout, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.
Claims42
A method of treating gout in a subject, the method comprising administering an anti-IL-1β antibody or fragment thereof to the subject.
(canceled)
5-9. (canceled)
20-24. (canceled)
27-28. (canceled)
31-35. (canceled)
(canceled)
43-44. (canceled)
46-48. (canceled)
50-51. (canceled)
53-54. (canceled)
The use of an anti-IL-1β antibody or fragment thereof which has a lower IC50 than an IL-1β receptor antagonist in a human whole blood IL-1β inhibition assay that measures IL-1β induced production of IL-8, in the manufacture of a composition for use in the treatment of gout.
Dependencies are inferred from the claim text.